Recently, our vaccine manufacturer partners announced changes to their catalog pricing. Members trying to place orders before the pricing changes on Sanofi and Pfizer vaccines should note the following deadlines.
- New Merck pricing effective 11/10/2021. In addition the FDA approved Vaxneuvance™, Merck’s 15-valent pneumococcal conjugate vaccine. Vaxneuvance™ protects against strains of pneumonia and other acute respiratory diseases.
- New Sanofi Pasteur pricing effective 1/1/2022. Please note that the final shipping date of 2021 is December 15th.
- New Pfizer pricing effective 2/23/2022. Pfizer’s FDA approved Prevnar 20™, is a 20-valent pneumococcal conjugate vaccine that prevents invasive diseases and pneumonia in adults age 18 years or older.
For updated pricing sheets, please contact the CPP office.
Managing a financially sustainable vaccine program is key to providing the most value to your practice and your patients. Don’t forget to access CPP’s price increase tools to help you manage through vaccine price increases. These include, but are not limited to, a budget impact worksheet, payer mix analysis and contact information for reimbursement support services available through the vaccine manufacturers.